(Q46190199)

20 December 2017

title

Lysosomal cysteine peptidase cathepsin L protects against cardiac hypertrophy through blocking AKT/GSK3beta signaling (English)

1 reference

20 December 2017

author name string

Qizhu Tang

1

1 reference

20 December 2017

Jun Cai

2

1 reference

20 December 2017

Difei Shen

3

1 reference

20 December 2017

Zhouyan Bian

4

1 reference

20 December 2017

Ling Yan

5

1 reference

20 December 2017

You-Xin Wang

6

1 reference

20 December 2017

Jie Lan

7

1 reference

20 December 2017

Guo-Qing Zhuang

8

1 reference

20 December 2017

Wen-Zhan Ma

9

1 reference

20 December 2017

Wei Wang

10

1 reference

20 December 2017

publication date

19 December 2008

1 reference

20 December 2017

Journal of Molecular Medicine

published in

1 reference

20 December 2017

volume

87

1 reference

20 December 2017

issue

3

1 reference

20 December 2017

page(s)

249-260

1 reference

20 December 2017

https://scigraph.springernature.com/pub.10.1007/s00109-008-0423-2

exact match

0 references

cites work

Identification of interleukin-8 converting enzyme as cathepsin L.

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00109-008-0423-2

Epigallocathechin-3 gallate inhibits cardiac hypertrophy through blocking reactive oxidative species-dependent and -independent signal pathways.

21 January 2018

1 reference

12 December 2020

Akt2 regulates cardiac metabolism and cardiomyocyte survival

1 reference

12 December 2020

Cysteine cathepsins: multifunctional enzymes in cancer

1 reference

12 December 2020

TNF provokes cardiomyocyte apoptosis and cardiac remodeling through activation of multiple cell death pathways

1 reference

12 December 2020

Lysosomal, cytoskeletal, and metabolic alterations in cardiomyopathy of cathepsin L knockout mice

1 reference

12 December 2020

Towards specific functions of lysosomal cysteine peptidases: phenotypes of mice deficient for cathepsin B or cathepsin L.

1 reference

12 December 2020

Proteolytic processing of dynamin by cytoplasmic cathepsin L is a mechanism for proteinuric kidney disease

1 reference

12 December 2020

Cathepsin L deficiency reduces diet-induced atherosclerosis in low-density lipoprotein receptor-knockout mice.

1 reference

12 December 2020

Curcumin prevents and reverses murine cardiac hypertrophy

1 reference

12 December 2020

TGFbeta, cardiac fibroblasts, and the fibrotic response

1 reference

12 December 2020

Cysteine cathepsin proteases as pharmacological targets in cancer

1 reference

12 December 2020

Calcineurin-NFAT signaling regulates the cardiac hypertrophic response in coordination with the MAPKs

1 reference

12 December 2020

Overexpression of myofibrillogenesis regulator-1 aggravates cardiac hypertrophy induced by angiotensin II in mice.

1 reference

12 December 2020

Cell type-specific functions of the lysosomal protease cathepsin L in the heart

1 reference

12 December 2020

Mitogen-activated protein kinases in heart development and diseases

1 reference

12 December 2020

Cathepsin cysteine proteases in cardiovascular disease.

1 reference

12 December 2020

Regulation of cardiac hypertrophy by intracellular signalling pathways

1 reference

12 December 2020

Myocardial proteases and matrix remodeling in inflammatory heart disease

1 reference

12 December 2020

Impaired cathepsin L gene expression in skeletal muscle is associated with type 2 diabetes

1 reference

12 December 2020

Dilated cardiomyopathy in mice deficient for the lysosomal cysteine peptidase cathepsin L.

1 reference

12 December 2020

Myocyte apoptosis in heart failure.

1 reference

12 December 2020

Regulation of cardiac growth and coronary angiogenesis by the Akt/PKB signaling pathway

1 reference

12 December 2020

Glycogen synthase kinase 3 (GSK3) in the heart: a point of integration in hypertrophic signalling and a therapeutic target? A critical analysis

1 reference

12 December 2020

Emerging roles of cysteine cathepsins in disease and their potential as drug targets.

1 reference

12 December 2020

10.1007/S00109-008-0423-2

Identifiers

DOI

1 reference

20 December 2017

PubMed ID

19096818

1 reference

20 December 2017